John A. Kellen

1.3k total citations
61 papers, 919 citations indexed

About

John A. Kellen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, John A. Kellen has authored 61 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Oncology. Recurrent topics in John A. Kellen's work include Alkaline Phosphatase Research Studies (10 papers), Estrogen and related hormone effects (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). John A. Kellen is often cited by papers focused on Alkaline Phosphatase Research Studies (10 papers), Estrogen and related hormone effects (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). John A. Kellen collaborates with scholars based in Canada, United States and Germany. John A. Kellen's co-authors include Aaron Malkin, D. J. Sutherland, A Kolín, Katerina Angelopoulou, Eleftherios P. Diamandis, Peter S. Bunting, Ross Cameron, Emmanuel Farber, G. Feuer and Kalman Kovacs and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and The Journal of Urology.

In The Last Decade

John A. Kellen

57 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Kellen Canada	14	344	318	170	97	93	61	919
Untae Kim United States	19	364 1.1×	308 1.0×	176 1.0×	85 0.9×	101 1.1×	39	1.2k
Dean Tsao United States	13	418 1.2×	188 0.6×	85 0.5×	68 0.7×	82 0.9×	22	746
Jones Lw United States	5	715 2.1×	380 1.2×	254 1.5×	91 0.9×	124 1.3×	6	1.4k
Edson J. Pontes United States	17	263 0.8×	252 0.8×	276 1.6×	90 0.9×	57 0.6×	24	1.0k
Norio Hirota Japan	21	323 0.9×	140 0.4×	245 1.4×	48 0.5×	72 0.8×	66	1.2k
Maria A. Cifone United States	15	431 1.3×	348 1.1×	394 2.3×	44 0.5×	82 0.9×	20	1.0k
Richard G. Bostedor United States	9	420 1.2×	254 0.8×	69 0.4×	39 0.4×	62 0.7×	10	752
Ulrich Kohnert Germany	17	354 1.0×	73 0.2×	246 1.4×	98 1.0×	102 1.1×	33	992
I Wodinsky United States	15	492 1.4×	331 1.0×	97 0.6×	50 0.5×	72 0.8×	69	979
Peter Ove United States	24	894 2.6×	190 0.6×	238 1.4×	93 1.0×	62 0.7×	54	1.7k

Countries citing papers authored by John A. Kellen

Since Specialization

Citations

This map shows the geographic impact of John A. Kellen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Kellen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Kellen more than expected).

Fields of papers citing papers by John A. Kellen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Kellen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Kellen. The network helps show where John A. Kellen may publish in the future.

Co-authorship network of co-authors of John A. Kellen

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Kellen. A scholar is included among the top collaborators of John A. Kellen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Kellen. John A. Kellen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kellen, John A.. (2003). The reversal of multidrug resistance: an update. PubMed. 3(1). 5–13. 30 indexed citations

Kellen, John A.. (2002). Gene therapy in cancer. PubMed. 2(6). 312–316. 3 indexed citations

Kellen, John A.. (2001). Raloxifene. Current Drug Targets. 2(4). 423–425. 7 indexed citations

Angelopoulou, Katerina, Eleftherios P. Diamandis, D. J. Sutherland, John A. Kellen, & Peter S. Bunting. (1994). Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. International Journal of Cancer. 58(4). 480–487. 180 indexed citations

Kellen, John A.. (1993). Reversal of Multidrug Resistance in Cancer. Medical Entomology and Zoology. 36 indexed citations

Kellen, John A., et al.. (1991). R-verapamil decreases anti-estrogen resistance in a breast cancer model.. PubMed. 11(2). 809–11. 3 indexed citations

Gardner, H. Allen, et al.. (1988). Characterization of Different Cell Subpopulations Derived from an Experimental Tumor Model. Cancer Investigation. 6(2). 161–165. 2 indexed citations

Acevedo, Hernan F., et al.. (1987). Expression of Human Choriogonadotropin-Like Material Correlates with Metastatic Phenotype of R3230 AC Rat Adenocarcinoma. Cancer Investigation. 5(3). 177–185. 5 indexed citations

Malkin, Aaron, et al.. (1985). The presence of glycosylated, biologically active chorionic gonadotropin in human liver. Clinical Biochemistry. 18(2). 75–77. 2 indexed citations

10.

Teodorczyk-Injeyan, Julita A., et al.. (1983). The Effect of Tranexamic Acid on Growth and Spread of an Experimental Tumor Model. The Journal of Urology. 130(4). 831–831. 1 indexed citations

11.

Drahovský, Dušan, et al.. (1981). Reevaluation of C-Reactive Protein in Cancer Sera by Radioimmunoassay and Radial Immunodiffusion. Oncology. 38(5). 286–291. 18 indexed citations

12.

Myers, Robert E., et al.. (1979). Prognostic Value of Postoperative Blood Levels of Carcinoembryonic Antigen (CEA) in Breast Cancer. Recent results in cancer research. 67. 26–32. 5 indexed citations

13.

Cameron, Ross, John A. Kellen, A Kolín, Aaron Malkin, & Emmanuel Farber. (1978). Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis.. Library Stack (Library Stack). 38(3). 823–9. 174 indexed citations

14.

Myers, Robert E., et al.. (1978). Carcinoembryonic antigen in breast cancer. Cancer. 42(S3). 1520–1526. 60 indexed citations

15.

Kellen, John A.. (1973). Induction of Rat Mammary Tumours in Altered Iodine Metabolism. Oncology. 28(3). 269–273. 2 indexed citations

16.

Kellen, John A.. (1973). Suppression of DMBA-tumour induction in rat mammary glands by pregnancy or chlorotrianisene. Journal of Cancer Research and Clinical Oncology. 79(2). 75–7. 2 indexed citations

17.

Kellen, John A.. (1972). Effect of Hypothyroidism on Induction of Mammary Tumors in Rats by 7,12-Dimethylbenz[<italic>a</italic>]anthracene<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 48(6). 1901–4. 20 indexed citations

18.

Lo, Jennifer & John A. Kellen. (1971). Demonstration of the Subunit Structure of HumanPlacental Alkaline Phosphatase by Isoelectric Focusing. Enzyme. 12(6). 635–641. 3 indexed citations

19.

Kellen, John A. & Viliam Lustig. (1971). Patterns of Amino-acid Inhibition of Alkaline Phosphatases as an Aid in Cancer Diagnosis. Oncology. 25(3). 239–248. 4 indexed citations

20.

Anderson, K.M. & John A. Kellen. (1970). Suppression of carcinogen-induced rat mammary tumor formation by Actinomycin D. Cellular and Molecular Life Sciences. 26(9). 1000–1001. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact